spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  PARP 

 HSMN NewsFeed - 8 Dec 2022
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Feb 2021
Cyteir Therapeutics Secures $80 Million in Series C Financing to Advance Clinical Trials of Lead RAD51 Program
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2021
Endo Launches Authorized Generic Version of Amitiza(R) (lubiprostone) Capsules in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 9 Sep 2020
Phosplatin Therapeutics Announces Two Leadership Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Mar 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Jan 2020
Theragnostics Expands Team with Significant Appointments
Biopharmaceuticals Oncology Radiology Personnel
 HSMN NewsFeed - 15 Oct 2019
Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing and Doses First Patient in Phase 1/2 Study of First-in-Class RAD51 Inhibitor
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 3 Sep 2019
Endo Launches Authorized Generic Version of Noxafil(R) (posaconazole) Delayed-release Tablets in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 5 Apr 2019
Endo Begins Shipment of Authorized Generic Version of PROVENTIL(R) (albuterol sulfate) HFA Inhalation Aerosol in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Obtains Debt Facility from Silicon Valley Bank to Acquire and Advance Momelotinib
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 27 Jul 2018
Endo Begins Shipment of Authorized Generic Version of INVANZ(R) (ertapenem for injection) in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 24 May 2018
Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Mar 2018
Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Dec 2016
Foundation Medicine Receives FDA Approval of FoundationFocus(TM) CDxBRCA as a Companion Diagnostic for Rubraca(TM) (rucaparib) for the Treatment of Women with Ovarian Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 7 Nov 2016
Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDx(R)
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 22 Aug 2016
Pfizer to Acquire Medivation
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 6 Apr 2016
Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 18 Mar 2016
The Myriad myRisk(R) Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Dec 2015
Stryker Introduces New Advanced Imaging Modalities To Minimally Invasive Surgery With The 1588 AIM Platform
Devices Surgery Product Launch
 HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jan 2015
Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 12 Nov 2014
Par Pharmaceutical Announces First FDA Approval of Vasostrict(TM) (vasopressin injection, USP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Oct 2014
Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe
Diagnostics Oncology
 HSMN NewsFeed - 1 Apr 2014
Par Pharmaceutical Names Terrance J. Coughlin Chief Operating Officer
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 15 Jan 2014
AbbVie Announces Initiation of Pivotal Phase 3 Study of Veliparib (ABT-888) for Patients with Early-Stage Triple-Negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jan 2014
BioMarin Announces Selection of Factor VIII Gene Therapy Drug Development Candidate BMN 270 for the Treatment of Hemophilia A
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2013
Par Pharmaceutical Begins Shipment of Generic Kapvay(R)
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 25 Sep 2013
Par Pharmaceutical Begins Shipment of Generic Glucotrol XL(R)
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 3 Sep 2013
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2013
Par Pharmaceutical Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 May 2013
Par Pharmaceutical Begins Shipment of Generic Atacand(R)
Biopharmaceuticals Cardiology Generics Distribution
 HSMN NewsFeed - 12 Nov 2012
Clovis Oncology Announces Negative Outcome of CO-101 in Pivotal LEAP Pancreatic Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Sep 2012
Par Announces Completion Of Acquisition By TPG
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 5 Sep 2012
BioMarin Names Jeff Ajer Senior Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2012
Par Pharmaceutical Begins Shipment of Generic Provigil(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 24 Aug 2011
Par Pharmaceutical To Acquire Anchen Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 May 2011
Par Pharmaceutical to Acquire Edict Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2010
John A. MacPhee Resigns From Strativa Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2010
Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2010
Par Pharmaceutical Enters Into Agreement With sanofi-aventis to Settle Patent Litigation Over Generic Eloxatin(R)
Biopharmaceuticals Generics Oncology Litigation
 HSMN NewsFeed - 4 Feb 2010
BioMarin to Acquire LEAD Therapeutics
Biopharmaceuticals Mergers & Acquisitions Oncology
 HSMN NewsFeed - 1 Dec 2009
Canaan Partners Appoints Tim Shannon, M.D. as Venture Partner
Venture Capital Personnel
 HSMN NewsFeed - 10 Sep 2009
Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)
Biopharmaceuticals Generics Endocrinology FDA
 HSMN NewsFeed - 18 Aug 2009
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jun 2009
Thomas P. Rice Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2009
Strativa's New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 9 Jun 2009
Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 21 Apr 2009
Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR
Biopharmaceuticals Litigation
 HSMN NewsFeed - 1 Apr 2009
Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2009
Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Oct 2008
Gerard A. Martino Resigns as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2008
Par Pharmaceutical Announces Resizing of Generic Unit to Optimize Strong First-to-File Pipeline
Biopharmaceuticals Generics
 HSMN NewsFeed - 1 Oct 2008
Inotek Appoints Paul G. Howes as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2008
Par Pharmaceutical to Launch meclizine HCL Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 May 2008
Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2008
Inotek Focuses Resources on Clinical Programs, Adds to Executive Management Team and Consolidates Operations in Massachusetts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2008
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2008
Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Sep 2007
BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2007
BiPar Names G. Kirk Raab Acting Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Aug 2007
Inotek Pharmaceuticals Secures $19 million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Aug 2007
NovaDel Announces Sublicense Agreement for Zensana(TM)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 1 Aug 2007
Hana Biosciences Licenses North American Commercial Rights for Zensana(TM) to Par Pharmaceutical in a $50 Million Deal
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Jul 2007
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 3 Jul 2007
Par Pharmaceutical Licenses U.S. Commercialization Rights to Loramyc(TM) From BioAlliance Pharma
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Jun 2007
Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jun 2007
Immtech and Par Enter Licensing Agreement on Pafuramidine for Treatment of Pneumocystis Pneumonia
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 7 Jun 2007
Par Pharmaceutical Names Gerard A. Martino EVP and COO, Veronica A. Lubatkin EVP and CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2007
Next Generation of Investigational Anti-Cancer Agents Unveiled at ASCO by AstraZeneca
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Mar 2007
Melvin Sharoky Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2007
Par Pharmaceutical Names Paul Campanelli President, Generics Division
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 14 Feb 2007
Inotek Pharmaceuticals Announces Additions to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2007
Par Pharmaceutical Receives Approval of Generic Inderal-LA(R)
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 26 Dec 2006
Par Pharmaceutical Receives Approval for Ondansetron Orally Disintegrating Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Nov 2006
Par Pharmaceutical Begins Shipment of Generic TOPROL-XL(R)
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 13 Nov 2006
Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Nov 2006
NovaDel Pharma Receives FDA Approval of NitroMist(TM)
Biopharmaceuticals Drug Delivery FDA Cardiology
 HSMN NewsFeed - 2 Nov 2006
Par Announces Termination of Cesamet(TM) Promotion Agreement
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2006
Par Pharmaceutical Begins Shipment of Pravastatin Tablets
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 26 Sep 2006
Patrick G. LePore Named President and Chief Executive Officer of Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2006
Par Pharmaceutical Announces Agreement With Unimed Pharmaceuticals to Settle AndroGel(R) Patent Litigation
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 19 Jul 2006
Par Pharmaceutical Receives Final Approval to Market Meloxicam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Jun 2006
Par Pharmaceutical Receives Final Approval to Market Tranylcypromine Sulfate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2006
Par Pharmaceutical Receives Final Approval to Market Polyethylene Glycol 3350 for Oral Solution
Biopharmaceuticals Generics FDA
Return to NewsFeed  

 Additional items found! 66

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 66 additional stories matching:
PARP
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.